With the increase of population aging, the number of Alzheimer's disease (AD) patients is
also increasing. According to current estimates, approximately 11% of people over 65 suffer …

One of the pathological hallmarks of Alzheimer's disease (AD) is the presence of
extracellular plaques resulting from the accumulation of beta-amyloid peptide (Aβ). To date …

Alzheimer's disease (AD) is an irreversible neurodegenerative disorder that affects more
than 44 million people worldwide. Despite the high disease burden, there is no effective …

Mesenchymal stem cells (MSCs) are a type of versatile adult stem cells present in various
organs. These cells give rise to extracellular vesicles (EVs) containing a diverse array of …

Neurodegenerative diseases are characterized by the progressive loss of neurons and
intricate interactions between different cell types within the affected regions. Reliable …

The term extracellular vesicles (EVs) refers to a variety of heterogeneous nanovesicles
secreted by almost all cell types, primarily for intercellular communication and maintaining …

No cure yet exists for devastating Alzheimer's disease (AD), despite many years and
humongous efforts to find efficacious pharmacological treatments. So far, neither designing …

Neurodegenerative diseases represent a growing burden on healthcare systems worldwide.
Mesenchymal stem cells (MSCs) have shown promise as a potential therapy due to their …

Alzheimer's disease is a severe, highly disabling neurodegenerative disease, clinically
characterized by a progressive decline in cognitive functions, and is the most common form …

Mesenchymal stem cells (MSCs) are multipotent, adult stem cells which are found in
numerous tissues like the umbilical cord, Wharton's jelly, bone marrow, and adipose tissue …